Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

Myriad Genetics’ first quarter results were met with a significant negative market reaction, reflecting investor concerns over a combination of volume softness in key product lines and a reset ...

Read about Myriad Genetics Inc (MYGN:XNAS) stock and today's latest news and financial updates.

Myriad Genetics’ first quarter results were met with a significant negative market reaction, reflecting investor concerns over a combination of volume softness in key product lines and a reset ...

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market ...

Myriad Genetics Inc. Annual stock financials by MarketWatch. View the latest MYGN financial statements, income statements and financial ratios.

CSHL’s Lippman and McCandlish labs have discovered how interactions between cryptic genetic mutations can increase or decrease the number of reproductive branches on tomato plants. The scientists’ ...

British scientists have created eight children in a lab over the past two years whose health continues to be monitored in hopes of determining if research methods that incorporate a third parent in ...

In the search for a "no maintenance" plant, daylily is about as close as one can get. Indeed, it often is mused "daylilies thrive on neglect." Few garden flowers give so much pleasure while "asking" ...

When it comes to groundbreaking biotech advancements, Eric Faw Intellia is a name you might wanna keep an eye on. This ...

Overview of Companion Diagnostics MarketThe Companion Diagnostics Market is evolving rapidly, driven by the growing demand ...